# Ibuprofen

## Pedea inj 10mg/2mL \(專案進口\)

| 藥物代碼 | IPEDE |
| :--- | :--- |
| 適應症 | Treatment of Patent Ductus Arteriosus \(PDA\) in premature neonates \(&gt;34 weeks' gestational age\) |
| 副作用 | For Pedea sepsis, anemia, bleeding, apnea, adverse GI effects, renal impairment, respiratory tract infection, dermatologic effects, hypoglycemia, hypocalcemia, respiratory failure.Cardiovascular: Hypotension \(intravenous, up to 10% \)Dermatologic: Rash \(oral, 3% to 9% \)Endocrine metabolic: Hypernatremia \(intravenous, up to 10% \), Hypoalbuminemia \(intravenous, 3% to 10% \), Hypoproteinemia \(intravenous, up to 13% \), Serum lactate dehydrogenase level elevated \(intravenous, 3% to 10% \)Gastrointestinal: Flatulence \(injection, 7% to 16% \), Heartburn \(oral, 3% to 9% \), Nausea \(oral, 3% to 9%; intravenous, 53% to 57% \), Vomiting \(oral, 1% to 3%; intravenous, 15% to 22% \)Hematologic: Thrombocytosis \(intravenous, 3% to 10% \)Immunologic: Bacteremia \(injection, 13% \)Neurologic: Dizziness \(oral, 3% to 9%; intravenous 4% to 6% \), Headache \(oral, 1% to 3%; intravenous, 9% to 11% \)Renal: Serum blood urea nitrogen raised \(intravenous, up to 10% \), Urinary retention \(intravenous, 3% to 5% \)Respiratory: Bacterial pneumonia \(intravenous, 3% to 10% \) |
| 禁忌 | for Pedea: untreated infection, bleeding, thrombocytopenia; coagulation defects, necrotizing enterocolitis, renal impairment, congenital heart disease if patency of the ductus arteriosus is necessary for pulmonary or systemic blood flow \(e.g., pulmonary atresia, severe tetralogy of Fallot, severe coarctation of the aorta\). |
| 藥物保存方式 | N/A |
| 用法用量 | PDA: Each course of therapy consists of 3 doses administered at 24-hour intervals. First dose is 10 mg/kg; second and third doses are 5 mg/kg each, If anuria or oliguria \(urine output &lt;0.6 mL/kg per hour\) withhold the dose until renal function has returned to normal. If ductus arteriosus fails to close or reopens, a second course of ibuprofen, may be needed |
| 肝功能異常 | 無需調整劑量 |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 儘量避免 |
| 孕期用藥建議 | Human data suggest risk in 1st and 3rd trimester |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | Compatible 哺乳時可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | IVD |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | 【D5W】 可選  【N/S】 可選 |
| IVP 用法建議 | N/A |
| IVD 用法建議 | 輸注時間至少 15分鐘 |
| 注意事項 | Pedea should be administered as a short infusion over 15 minutes, preferably undiluted. To facilitate the administration an infusion pump may be used. |

## Idofen 20mg/mL 120mL suspension

| 藥物代碼 | LIDO1 |
| :--- | :--- |
| 適應症 | Relief of pain, inflammation & fever. |
| 副作用 | GI effects including ulceration; rashes; bronchospasm. Rarely, thrombocytopenia. |
| 禁忌 | Peptic ulceration; patients in whom attacks of asthma, angioedema, urticaria or rhinitis are precipitated by aspirin & other NSAIDs. |
| 懷孕用藥危分級 | 可能安全 |
| 孕期用藥建議 | Human data suggest risk in 1st and 3rd trimester |
| 附帶說明 | \[20201124非類固醇消炎藥品安全資訊風險溝通表\] 懷孕20週以上孕婦使用NSAIDs可能會導致胎兒腎功能障礙並導致羊水過少； 妊娠30週以上之孕婦可能導致胎兒動脈導管過早閉合的風險。 |
| 哺乳期用藥建議 | Compatible 哺乳時可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | AC, AC15, PC, PO, WM |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

